MC2226A1 - Oxetannones - Google Patents

Oxetannones

Info

Publication number
MC2226A1
MC2226A1 MC912172A MC2172A MC2226A1 MC 2226 A1 MC2226 A1 MC 2226A1 MC 912172 A MC912172 A MC 912172A MC 2172 A MC2172 A MC 2172A MC 2226 A1 MC2226 A1 MC 2226A1
Authority
MC
Monaco
Prior art keywords
methyl
oxo
group
oxetanyl
dodecyl
Prior art date
Application number
MC912172A
Other languages
English (en)
French (fr)
Inventor
Derungs Romano
Peter Maerki Hans
Stalder Henri
Szente Andre
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2226A1 publication Critical patent/MC2226A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
MC912172A 1990-02-26 1991-02-21 Oxetannones MC2226A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH400590 1990-12-17

Publications (1)

Publication Number Publication Date
MC2226A1 true MC2226A1 (fr) 1993-02-02

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912172A MC2226A1 (fr) 1990-02-26 1991-02-21 Oxetannones

Country Status (18)

Country Link
EP (1) EP0444482B1 (pt)
JP (1) JP2753403B2 (pt)
KR (1) KR0183036B1 (pt)
AT (1) ATE133167T1 (pt)
AU (1) AU645291B2 (pt)
CA (1) CA2035967C (pt)
DE (1) DE59107262D1 (pt)
DK (1) DK0444482T3 (pt)
ES (1) ES2082869T3 (pt)
FI (1) FI115054B (pt)
GR (1) GR3019618T3 (pt)
HU (1) HU218272B (pt)
IE (1) IE72196B1 (pt)
IL (1) IL97148A (pt)
MC (1) MC2226A1 (pt)
NO (1) NO177055C (pt)
NZ (1) NZ237170A (pt)
PT (1) PT96887B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
NL1004559C2 (nl) * 1996-11-18 1998-05-19 Unilife Boter.
CN1342169A (zh) * 1999-10-29 2002-03-27 约翰·贾森·金特里·穆林斯 氧杂环丁烷酮衍生物
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO2009059046A1 (en) 2007-10-31 2009-05-07 Burnham Institute For Medical Research Beta-lactone compounds
PL4218753T3 (pl) * 2017-07-12 2026-04-20 Mayo Foundation For Medical Education And Research Nowe inhibitory lipazy i ich zastosowania

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) * 1984-08-09 1994-08-31 三菱電機株式会社 遅延線

Also Published As

Publication number Publication date
NO910729L (no) 1991-08-27
NZ237170A (en) 1993-12-23
JP2753403B2 (ja) 1998-05-20
HU218272B (en) 2000-07-28
IL97148A0 (en) 1992-05-25
FI115054B (fi) 2005-02-28
GR3019618T3 (en) 1996-07-31
PT96887B (pt) 1998-09-30
JPH0770099A (ja) 1995-03-14
IE72196B1 (en) 1997-03-26
DK0444482T3 (da) 1996-05-06
IE910631A1 (en) 1991-08-28
CA2035967A1 (en) 1991-08-27
ATE133167T1 (de) 1996-02-15
EP0444482A2 (de) 1991-09-04
IL97148A (en) 1996-11-14
AU7122891A (en) 1991-08-29
AU645291B2 (en) 1994-01-13
FI910925L (fi) 1991-08-27
NO177055C (no) 1995-07-12
FI910925A0 (fi) 1991-02-26
HUT56557A (en) 1991-09-30
ES2082869T3 (es) 1996-04-01
EP0444482A3 (en) 1991-12-04
PT96887A (pt) 1991-10-31
EP0444482B1 (de) 1996-01-17
NO177055B (no) 1995-04-03
CA2035967C (en) 2001-10-16
KR910021391A (ko) 1991-12-20
NO910729D0 (no) 1991-02-25
KR0183036B1 (ko) 1999-05-01
DE59107262D1 (de) 1996-02-29

Similar Documents

Publication Publication Date Title
US5260310A (en) Oxetanone compounds and pharmaceutical compositions containing them
US20030092634A1 (en) Novel compounds and compositions as protease inhibitors
MC1639A1 (fr) Derives de la glycerine
FR2606018A1 (fr) Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments
EP1009750B1 (fr) Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et leurs applications therapeutiques
DE60010747T2 (de) Neue trisubstituierte phenyl-derivate und analoga
MC1476A1 (fr) Derives de la pyrrolidine
MC2226A1 (fr) Oxetannones
JP4428053B2 (ja) ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
BE1003848A3 (fr) Nouveaux derives de la thiouree, leur preparation et leur utilisation comme medicaments.
MC1417A1 (fr) Derives tetrasubstitues du benzene
FR2568248A1 (fr) Nouveaux composes naphtaleniques, leur preparation et leur application comme medicaments
MC1757A1 (fr) Dérivés du glycérol
EP1651596B1 (fr) Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
CA2329637A1 (fr) Derives d'(alpha-aminophosphino) peptides et compositions les contenant
BE890948A (fr) Derives de l'acide anthranilique
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
FR2706897A1 (pt)
EP0005422A2 (fr) Dérivés d'acides oméga-dialkylalkanoiques, leurs procédés de préparation ainsi que leur utilisation en thérapeutique
MC1145A1 (fr) Procede de preparation d'amides de l'acide aminoacetique(glycocolle)
EP0177390A1 (fr) Dérives de diphénylazométhines à chaîne insaturée, leur préparation et leur application en thérapeutique
FR2477539A1 (fr) Derives de 1-((2-mercaptocycloalkyl)-carbonyl)-l-prolines, procede pour leur preparatitn, produits intermediaires de leur synthese et leur utilisation en tant qu'agents anti-hypertenseurs